Find trials
Consejos para buscar

A Study of a Sleep Health ‘App’ to Help First-Time Users of Positive Airway Pressure Therapy for Sleep Apnea

Overview

Información sobre este estudio

The purpose of this study is to test the usefullness and initial effectiveness of an mHealth smartphone app to increase use of positive airway pressure (PAP) therapy in obstructive sleep apnea (OSA) patients treated at the Mayo Clinic Arizona Center for Sleep Medicine.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

CLOSED FOR ENROLLMENT

Inclusion Criteria

  • Age 21+ years
  • Positive screen for moderate to severe obstructive sleep apnea using the Sleep Apnea Clinical Score screener
  • Clinical diagnostic testing via laboratory or home-based sleep study indicates diagnosis of obstructive sleep apnea
  • Currently uses an appropriate Apple (iOS7 or higher) or Android (2.3 or higher) smartphone device
  • Is able to read and understand English
  • Has been prescribed PAP treatment for obstructive sleep apnea

Exclusion Criteria 

  • Does not agree to be randomized
  • Is currently participating in other lifestyle programs (e.g., active, formal weight loss program or research study; smoking cessation program, etc.)
  • Has lost 10lb or 4.5kg over the past 4 weeks
  • Has personal, health (e.g., stroke), cognitive (e.g., dementia) or psychological conditions that prevent participation
  • Is pregnant, lactating, or trying to become pregnant
  • Decide to use different device than ResMED Airsense 10
  • Prescribed high-dose benzodiazepines (equivalent to >1 mg lorazapam/night)
  • Daily opioid medication use at night
  • Unwilling to discontinue use of any current wearable sensor for the duration of the trial
  • Unwilling to consent for out-of-pocket costs
  • Previous documented history of treatment/referral for claustrophobia
  • Previous PAP use
  • Other conditions determined by a sleep medicine team member that may interfere with full participation in the trial
  • Planning to travel for more than seven consecutive nights during the trial
  • Currently engaging in shiftwork defined as night shift or rotating day and night shifts
  • Unwilling to have an in-person follow-up appointment at the Center for Sleep Medicine, Arizona

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus

Scottsdale/Phoenix, Ariz.

Investigador principal de Mayo Clinic

Lois Krahn, M.D.

Cerrado para la inscripción

Rochester, Minn.

Investigador principal de Mayo Clinic

John Park, M.D.

Cerrado para la inscripción

More information

Publicaciones

Publications are currently not available

Otros temas en investigación

.
CLS-20258281

Mayo Clinic Footer